Immunic, Inc. to Participate in Investor Conference in December

PR Newswire06:30 ET

B.Riley Financial Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $6

Moomoo News01:32 ET · Ratings

Immunic's Promising Pipeline Progress and Stable Financials Justify Buy Rating

TipRanks01:05 ET · Ratings

Immunic Price Target Announced at $10.00/Share by HC Wainwright & Co.

Dow JonesNov 25 08:35 ET · Ratings

Express News | Immunic, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating

ReutersNov 25 06:02 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Fulcrum Therapeutics (FULC) and Immunic (IMUX)

TipRanksNov 19 02:20 ET · Ratings